we analyzed the drug sensitivity of 50 breast cancer cell lines according to WHSC1L1 expression. We found five anticancer drugs that most effectively reduced the growth of breast cancer cells with high WHSC1L1 expression: VX-11e, CZC24832, LY2109761, oxaliplatin and erlotinib